121 related articles for article (PubMed ID: 3337908)
1. An apparently higher molecular weight gamma-chain variant in a new congenital abnormal fibrinogen Tochigi characterized by the replacement of gamma arginine-275 by cysteine.
Yoshida N; Ota K; Moroi M; Matsuda M
Blood; 1988 Feb; 71(2):480-7. PubMed ID: 3337908
[TBL] [Abstract][Full Text] [Related]
2. Characterization of an apparently lower molecular weight gamma-chain variant in fibrinogen Kyoto I. The replacement of gamma-asparagine 308 by lysine which causes accelerated cleavage of fragment D1 by plasmin and the generation of a new plasmin cleavage site.
Yoshida N; Terukina S; Okuma M; Moroi M; Aoki N; Matsuda M
J Biol Chem; 1988 Sep; 263(27):13848-56. PubMed ID: 2971046
[TBL] [Abstract][Full Text] [Related]
3. A lower molecular weight gamma-chain variant in a congenital abnormal fibrinogen (Kyoto).
Yoshida N; Okuma M; Moroi M; Matsuda M
Blood; 1986 Sep; 68(3):703-7. PubMed ID: 3742050
[TBL] [Abstract][Full Text] [Related]
4. Heterozygous abnormal fibrinogen Osaka III with the replacement of gamma arginine-275 by histidine has an apparently higher molecular weight gamma-chain variant.
Yoshida N; Imaoka S; Hirata H; Matsuda M; Asakura S
Thromb Haemost; 1992 Nov; 68(5):534-8. PubMed ID: 1455400
[TBL] [Abstract][Full Text] [Related]
5. Fibrinogen Kyoto III: a congenital dysfibrinogen with a gamma aspartic acid-330 to tyrosine substitution manifesting impaired fibrin monomer polymerization.
Terukina S; Yamazumi K; Okamoto K; Yamashita H; Ito Y; Matsuda M
Blood; 1989 Dec; 74(8):2681-7. PubMed ID: 2819242
[TBL] [Abstract][Full Text] [Related]
6. Fibrinogen Kyoto II, a new congenitally abnormal molecule, characterized by the replacement of A alpha proline-18 by leucine.
Yoshida N; Okuma M; Hirata H; Matsuda M; Yamazumi K; Asakura S
Blood; 1991 Jul; 78(1):149-53. PubMed ID: 2070049
[TBL] [Abstract][Full Text] [Related]
7. A new congenital abnormal fibrinogen Ise characterized by the replacement of B beta glycine-15 by cysteine.
Yoshida N; Wada H; Morita K; Hirata H; Matsuda M; Yamazumi K; Asakura S; Shirakawa S
Blood; 1991 May; 77(9):1958-63. PubMed ID: 2018836
[TBL] [Abstract][Full Text] [Related]
8. Substitution of gamma Arg-275 by Cys in an abnormal fibrinogen, "fibrinogen Osaka II". Evidence for a unique solitary cystine structure at the mutation site.
Terukina S; Matsuda M; Hirata H; Takeda Y; Miyata T; Takao T; Shimonishi Y
J Biol Chem; 1988 Sep; 263(27):13579-87. PubMed ID: 2971042
[TBL] [Abstract][Full Text] [Related]
9. Polymerization defect of fibrinogen Baltimore III due to a gamma Asn308----Ile mutation.
Bantia S; Bell WR; Dang CV
Blood; 1990 Apr; 75(8):1659-63. PubMed ID: 2328317
[TBL] [Abstract][Full Text] [Related]
10. Characterization of fibrinogen Milano I: amino acid exchange gamma 330 Asp----Val impairs fibrin polymerization.
Reber P; Furlan M; Rupp C; Kehl M; Henschen A; Mannucci PM; Beck EA
Blood; 1986 Jun; 67(6):1751-6. PubMed ID: 3708159
[TBL] [Abstract][Full Text] [Related]
11. Plasmic degradation of fibrinogen Paris I.
Budzynski AZ; Marder VJ
J Lab Clin Med; 1976 Nov; 88(5):817-25. PubMed ID: 978044
[TBL] [Abstract][Full Text] [Related]
12. A re-examination of the cleavage of fibrinogen and fibrin by plasmin.
Ferguson EW; Fretto LJ; McKee PA
J Biol Chem; 1975 Sep; 250(18):7210-8. PubMed ID: 126232
[TBL] [Abstract][Full Text] [Related]
13. Fibrinogen Nagoya, a replacement of glutamine-329 by arginine in the gamma-chain that impairs the polymerization of fibrin monomer.
Miyata T; Furukawa K; Iwanaga S; Takamatsu J; Saito H
J Biochem; 1989 Jan; 105(1):10-4. PubMed ID: 2738036
[TBL] [Abstract][Full Text] [Related]
14. A congenitally abnormal fibrinogen (Vlissingen) with a 6-base deletion in the gamma-chain gene, causing defective calcium binding and impaired fibrin polymerization.
Koopman J; Haverkate F; Briët E; Lord ST
J Biol Chem; 1991 Jul; 266(20):13456-61. PubMed ID: 2071611
[TBL] [Abstract][Full Text] [Related]
15. Fibrinogen Bastia (gamma 318 Asp-->Tyr) a novel abnormal fibrinogen characterized by defective fibrin polymerization.
Lounes KC; Soria C; Valognes A; Turchini MF; Soria J; Koopman J
Thromb Haemost; 1999 Dec; 82(6):1639-43. PubMed ID: 10613648
[TBL] [Abstract][Full Text] [Related]
16. Fibrinogen Matsumoto I: a gamma 364 Asp-->His (GAT-->CAT) substitution associated with defective fibrin polymerization.
Okumura N; Furihata K; Terasawa F; Nakagoshi R; Ueno I; Katsuyama T
Thromb Haemost; 1996 Jun; 75(6):887-91. PubMed ID: 8822581
[TBL] [Abstract][Full Text] [Related]
17. Fibrinogen St. Gallen I (gamma 292 Gly--> Val): evidence for structural alterations causing defective polymerization and fibrinogenolysis.
Stucki B; Schmutz P; Schmid L; Haeberli A; Lämmle B; Furlan M
Thromb Haemost; 1999 Feb; 81(2):268-74. PubMed ID: 10064005
[TBL] [Abstract][Full Text] [Related]
18. Fibrinogen Kaiserslautern (gamma 380 Lys to Asn): a new glycosylated fibrinogen variant with delayed polymerization.
Ridgway HJ; Brennan SO; Loreth RM; George PM
Br J Haematol; 1997 Dec; 99(3):562-9. PubMed ID: 9401066
[TBL] [Abstract][Full Text] [Related]
19. Fibrinogen Bern I: substitution gamma 337 Asn-->Lys is responsible for defective fibrin monomer polymerization.
Steinmann C; Reber P; Jungo M; Lämmle B; Heinemann G; Wermuth B; Furlan M
Blood; 1993 Oct; 82(7):2104-8. PubMed ID: 8400260
[TBL] [Abstract][Full Text] [Related]
20. A novel mutation in the fibrinogen Aα chain (Gly13Arg, fibrinogen Nanning) causes congenital dysfibrinogenemia associated with defective peptide A release.
Yan J; Luo M; Cheng P; Liao L; Deng X; Deng D; Lin F
Int J Hematol; 2017 Apr; 105(4):506-514. PubMed ID: 27933517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
